Podcasts about Drug

Golden Fleet Announcement Trump unveils plans for the construction of two massive battleships, described as: The largest ever built. “100 times more powerful” than previous Iowa-class ships. Part of a new Golden Fleet to revitalize U.S. naval power. Long-term vision: expand to 20–25 ships, boosting American shipbuilding and jobs. Emphasis on national security, military supremacy, and economic benefits. Press Conference Highlights Trump positions himself as “the most transparent president in modern history”, answering questions on: China, Venezuela, Iran, and oil tanker seizures. Drug trafficking from Colombia. U.S. investment and tariffs. Healthcare insurer meetings. Epstein files and photos involving Bill Clinton. Epstein Files Discussion Trump expresses discomfort with photos of Bill Clinton being released but frames the issue as a Democratic distraction from Republican successes. Criticizes political opponents for using Epstein controversy to deflect from his administration’s achievements. Economic & Trade Themes Claims trillions in foreign investment flowing into the U.S. due to tariffs and pro-business policies. Projects $18 trillion in investments within 10 months, aiming for $20 trillion. Please Hit Subscribe to this podcast Right Now. Also Please Subscribe to the The Ben Ferguson Show Podcast and Verdict with Ted Cruz Wherever You get You're Podcasts. And don't forget to follow the show on Social Media so you never miss a moment! Thanks for Listening X: https://x.com/benfergusonshowYouTube: https://www.youtube.com/@VerdictwithTedCruzSee omnystudio.com/listener for privacy information.

Are you happy? What do you think is missing in your life? This episode challenges the way you think about happiness. Happiness can be like a drug: Over time, your body adjusts and you need more just to feel the same effect. What many don't realize is that joy is different. Don't become a fiend. Discover how to experience real joy without becoming addicted to the chase.Ecclesiastes 2 NLTActs 16Galatians 6:8TikTok: @CLWhiteside Instagram: @Championlife23  

Holiday Wrap-Up, Tesla Vandalism, and Rising Drug Threats (Hour 4) full 2134 Tue, 23 Dec 2025 15:39:26 +0000 WSYIQHNXwKexYFqIBoJi0ORslzCac0lf news,politics,news commentary The Marc Cox Morning Show news,politics,news commentary Holiday Wrap-Up, Tesla Vandalism, and Rising Drug Threats (Hour 4) The Marc Cox Morning Show is your home for no-nonsense conversation. Marc Cox is a political junkie and recovering journalist who has spent decades reporting on the biggest news of the day. Now he gets to talk about it. 2024 © 2021 Audacy, Inc. News Politics News Commentary False https://player.amperwavepo

AP correspondent Karen Chammas reports on a U.S. strike on a vessel in the Eastern Pacific which it claims was drug smuggling.

Drug expiration dates reflect the time period during which the product is known to remain stable, which means it retains its strength, quality, and purity when it is stored according to its labeled storage conditions. Drivers hitting the road for Thanksgiving will find gasoline prices virtually unchanged from a year ago, still sitting at the lowest point for the holiday since the pandemic – and the White House says Democrat-led states are to blame for the national average not being lower. Philip Teresi on KMJ ----------------------------------------------------------- Please Like, Comment and Follow 'Philip Teresi on KMJ' on all platforms: --- Philip Teresi on KMJ is available on the KMJNOW app, Apple Podcasts, Spotify, YouTube or wherever else you listen to podcasts. -- Philip Teresi on KMJ Weekdays 2-6 PM Pacific on News/Talk 580 AM & 105.9 FM KMJ | Website | Facebook | Instagram | X | Podcast | Amazon | - Everything KMJ KMJNOW App | Podcasts | Facebook | X | Instagram See omnystudio.com/listener for privacy information.

The Stoxx 600 reaches a new intra-day high with investors now anticipating the U.S. GDP print later today. Drug giant Novo Nordisk sees its shares soar as it seeks to gain U.S. approval for the pill-form version of its weight-loss drug Wegovy. President Trump has reiterated previous calls for acquiring Greenland from Denmark for national security reasons as he appoints a new envoy to the Arctic territory. See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Learn more about your ad choices. Visit megaphone.fm/adchoices

A drug raid in Tennessee uncovers a man overdosing on the floor while others inside the home use his body as a table, leading to arrests and a widening investigation. Police in New York stumble onto two baby crocodiles inside a home while making an arrest on unrelated charges. Drew Nelson reports.See omnystudio.com/listener for privacy information.

Today... A months-long investigation by the "7th Judicial District Drug Task Force" led to the December arrests of two Montrose men accused of working with a shared supplier to distribute fentanyl and methamphetamine, with formal charges expected in January. And later... "The Nature Connection" is expanding winter programs like climbing nights and cross-country ski pop-ups, backed by over one-hundred thousand dollars in new grants to support staff and create teen-focused outdoor opportunities.Support the show: https://www.montrosepress.com/site/forms/subscription_services/See omnystudio.com/listener for privacy information.

In this episode of Data in Biotech, Ross Katz sits down with Callie Celichowski and Isa Kupke from Veloxity Labs to discuss how their CRO leverages speed, precision, and innovation to support drug development. Learn how they use mass spectrometry, cloud-based infrastructure, and hands-on client partnerships to drive rapid, high-quality bioanalytical insights that support everything from preclinical studies to FDA submissions. What you'll learn in this episode: >> Why "speed with purpose" is essential for bioanalytical CROs supporting biotech and pharma clients >> The benefits and challenges of working with peptides and GLP-1 receptor agonists >> How the SCIEX 8600 enhances detection of low-concentration analytes Meet our guests Isa Kupke is Scientist II at Veloxity Labs, where she specializes in mass spectrometry and method development for preclinical and regulated bioanalytical programs. She also co-founded Blyde Botanics, bridging plant-based science and product development. Callie Celichowski is Senior Director of Business Development at Veloxity Labs, with over two decades in the pharmaceutical and CRO space. She's recognized for building strategic client partnerships and driving rapid, data-driven decision-making. About the host Ross Katz is Principal and Data Science Lead at CorrDyn. Ross specializes in building intelligent data systems that empower biotech and healthcare organizations to extract insights and drive innovation. Connect with Our Guest: Sponsor: CorrDyn, a data consultancyConnect with Isa Kupke on LinkedIn Connect with Callie Celichowski on LinkedIn  Connect with Us: Follow the podcast for more insightful discussions on the latest in biotech and data science.Subscribe and leave a review if you enjoyed this episode!Connect with Ross Katz on LinkedIn Sponsored by… This episode is brought to you by CorrDyn, the leader in data-driven solutions for biotech and healthcare. Discover how CorrDyn is helping organizations turn data into breakthroughs at CorrDyn.

Michael Leonard, Federal Defense Attorney at Leonard Trial Lawyers, joins Lisa Dent on the show to share details surrounding the recent reclassification of marijuana as a less dangerous drug per President Trump effective Thursday, December 18th.

In this episode I compare DMT experiences and some of the most famous alien abduction cases on record like the Betty and Barney Hill case. The similarities are fascinating!Thanks to the TIN FOIL MULISHAExclusive episodes on Patreon https://www.patreon.com/c/ufonopodcastJoin the Tin Foil Mulisha Discord:⁠ https://discord.gg/PQyaJzkt4Y⁠Paypal Donation ⁠https://www.paypal.com/ncp/payment/Y6WRSW9F2JBSCStripe Donation https://buy.stripe.com/aFa6oGeiXamjdlW39HgUM00Buy Merch⁠ https://ufono.dashery.com/ | https://ufono-podcast.creator-spring.com/Buy Mushrooms⁠ https://www.schedule35.co/us/ (Code: U1173687US240607)⁠Email: Iwant2believe115@gmail.comFollow: Facebook | Twitter | Twitch | Kick | RumbleStrassman, R. (2001). DMT: The Spirit Molecule. (Research summary via OPEN Foundation)Davis, A.K. et al. (2020). “Survey of entity encounter experiences occasioned by inhaled N,N-dimethyltryptamine.” J. Psychopharmacology, 34(9), 1008-1020.Taub, B. (2020). “People Seeing Strange Entities When Taking DMT Could Be the Source of ‘Alien Abductions'.” IFLScience (reporting on Davis et al. 2020 survey).Magee, T. (2023). “DMT Users Are Using AI to Draw the Strange Beings They Meet While Tripping.” Vice (interview with DMT researchers).Nichols, D. et al. (2023). “Why N,N-Dimethyltryptamine (DMT) matters: unique features and therapeutic potential beyond classical psychedelics.” *Front. Psychiatry, 15:*1485337pmc.ncbi.nlm.nih.govWikipedia contributors. “Perspectives on the alien abduction phenomenon – Drug-induced hallucinations.” Wikipedia (summarizing Strassman's findings).

UNDER THE CHRISTMAS LIGHTS - OUT NOW: https://wawdpod.com/lights-spotifyhttps://wawdpod.com/lights-apple-----Episode 217 is here. I start this one the only responsible way. By unboxing a Sheetz package and trying on six or seven different Sheetz shirts like I am getting paid in MTO coupons. I asked for “one of each,” and Sheetz said, “Bet. Hold my street taco.” So now I own enough shirts to dress an entire grand opening line in Camp Hill.We also need to talk about the Camp Hill Sheetz grand opening chaos. Fifty to a hundred people outside. Cars wrapped around the block. Ribbon cut. Holiday vibes. My next ask is simple. Put me on the schedule as the DJ for these openings. One day. One location. I bring the energy. I bring the bits. I wear an unreasonable amount of Sheetz merch and act like a functioning adult.Then we hit the news spiral. TGI Fridays went viral because a server walked a toddler around the restaurant, and corporate rewarded her with a $500 check after flying people out to do a filmed presentation. So of course the internet did the real bonus and a GoFundMe started cooking. After that, I pitch the only gift idea men want. A Godzilla costume and a cardboard city to destroy. Also, if you want the ultimate holiday hack, give your boss a Christmas card. You want to keep your job, go write “thanks for paying me” on a $3 card and live another day.We finish strong with media and politics chaos. Netflix is still trying to collect podcasts like Infinity Stones. Melania has a movie trailer and a production company, because why not. Trump announces big moves, including marijuana rescheduling talk, and then drops the Patriot Games, aka Hunger Games: Home Edition. It's a lot. So yes, I close the episode the same way I opened it. Confused. Laughing. Wearing a Sheetz shirt.Also, stream my Christmas song “Under the Christmas Lights” right now. Put it on repeat. You know what to do.**********Disclaimer: We at the What are We Doing podcast want to make it clear that the views and opinions expressed in this video belong solely to the speakers or authors and do not represent the views and opinions held by YouTube, its partners, or its owners.We must also emphasize that the information contained in this video has been produced with no warranty, expressed or implied, regarding the validity, accuracy, reliability, completeness, legality, or usefulness of what is said or expressed. Therefore, we strongly advise that no one viewing or listening to this video should rely on the information presented herein.We want to make it clear that the speakers or authors in this video express their views in an "artistic" manner as defined within the YouTube guidelines and that this video is purely for entertainment purposes only.

Twórcy słuchowiska politycznego „Stan Wyjątkowy" ujawniają najgłębiej skrywaną, świąteczną tajemnicę PiS. Otóż w partii były nie dwie - jak się dotąd wydawało - ale aż trzy wigilie. Pierwszą zrobił dla wszystkich pisowców prezes Jarosław Kaczyński. Drugą, dla swoich ludzi, były premier Mateusz Morawiecki. A najtajniejszą zorganizował były wicepremier Jacek Sasin. Jak mówią jedni, przy opłatku - pardon - "rzygał" on na Morawieckiego. Drudzy są bardziej dyplomatyczni. Twierdzą, że Sasin prowadził ze swymi gośćmi świąteczne dysputy o Polsce - Polsce bez Morawieckiego, rzecz jasna. W tym wydaniu „Stanu Wyjątkowego" ujawniamy też, co wynika z analiz Nowogrodzkiej w sprawie sytuacji na prawicy. Co musiałoby się stać, aby Kaczyńskiemu udało się odbić wyborców Grzegorzowi "Grigorijowi" Braunowi? Otóż najpierw trzeba zbić jego partię Korona do poziomu 5 proc., by w konsekwencji jego wyborcy uznali, że lepiej nie marnować głosu i postawić na PiS. Patrząc na notowania Brauna, to marzenie. Bardzo sprawnie, co przyznają w PiS, Donald Tusk przykleja bowiem prawicy twarz Grzegorza Brauna.  W części rozrywkowej programu mówimy, ile na walce w klatce zarobi były poseł PiS Przemysław Czarnecki, syn Ryszarda i były facet Marianny. On sam przyznaje, że jest póki co "jest bardziej freak niż fighter". Chyba pierwszy raz się z nim zgadzamy. Zapraszamy na wyjątkowe wydanie "Stanu Wyjątkowego", w którym prowadzący w konstytucyjnym składzie podsumują dla państwa 2025 rok w polskiej polityce. Pierwsza część już w drugi dzień świąt - 26 grudnia o godzinie 18. Więcej informacji pod tym linkiem: https://wiadomosci.onet.pl/kraj/podsumowanie-roku-ze-stanem-wyjatkowym-pierwsza-czesc-juz-w-drugi-dzien-swiat/lksfhl1 

Dave Rubin of "The Rubin Report" talks to Senator John Kennedy about the real world results of Trump's attacks on Venezuelan drug boats that Democrats would like to ignore; Congress racing to pass key legislation like the National Defense Authorization Act; how one GOP holdout could stall progress; why Republicans need to focus on lowering the cost of living through deregulation and economic reform ahead of the midterms; how a Democratic House could trigger impeachment chaos and gridlock; what makes Louisiana so unique; and much more. Check out the NEW RUBIN REPORT MERCH here: https://daverubin.store/ ----------  Today's Sponsors: Balance of Nature - Make sure you are getting all the positive effects from a wide variety of fruits and vegetables. Get 50% off the Whole Health System FOR LIFE with this limited-time offer! Go to https://www.BalanceofNature.com MASA Chips - MASA's chips contain just three ingredients: organic nixtamalized corn, sea salt, and 100% grass-fed beef tallow. That's it. No seed oils, no mystery chemicals, just real food. Ready to give MASA or Vandy a try? Get 25% off your first order. Go to http://masachips.com/RUBIN and use code RUBIN.  

The Justice Department just released a massive portion of files related to Jeffrey Epstein. We'll tell you about the US military's operation in Syria. Investigators face steep challenges trying to piece together a motive in the Brown University shooting. More pharmaceutical companies are joining President Donald Trump's push to lower drug prices. Plus, an update on the humanitarian situation in Gaza. Learn more about your ad choices. Visit podcastchoices.com/adchoices

White House and Democratic lawmakers weigh in on President Donald Trump's Wednesday night primetime TV year-end address, during which the president highlighted what he sees as his achievements after almost a year in office; Democrats make a last-ditch effort to get a vote to extend expiring Affordable Care Act health insurance premium subsidies; Health & Human Services Secretary Robert F. Kennedy, Jr. announces new rules that aim to prohibit gender-affirming care for transgender youth; President Trump signs an Executive Order to reclassify marijuana as a less dangerous drug, to ease restrictions and allow for more research. We will talk about it with Axios reporter Herb Scribner (30); White House says the Kennedy Center for the Performing Arts has been renamed by the board of trustees the Trump-Kennedy Center, but there are questions about whether it would take an act of Congress; House votes to require the gray wolf be removed from the Endangered Species Act list; Pope Leo XIV names a new Catholic Archbishop of New York, who is from Chicago, like the pope. Learn more about your ad choices. Visit megaphone.fm/adchoices

It's the Friday News Roundup! We're talking about wrapping up 2025 with the fewest homicides in decades. There's a new drug on our streets that's overwhelming our hospitals. And we're going to laugh off some of the biggest stories of the year. Host Trenae Nuri and executive producer Matt Katz also dish about their favorite City Cast episodes of 2025.  Our Friday news roundups are powered by great local journalism:  A Powerful New Drug Is Creating a ‘Withdrawal Crisis' in Philadelphia Celebrating Progress and Shaping Philadelphia's Future 10-year-old boy burned in Philadelphia plane crash returns home: "It's a miracle" A hidden alley could become a key walking path in Old City for 2026 Get Philly news & events in your inbox with our newsletter: Hey Philly Call or text us: 215-259-8170 We're also on Instagram: @citycastphilly And don't forget—you can support this show and get great perks by becoming a City Cast Philly Neighbor at membership.citycast.fm. Learn more about the sponsors of this episode: Fitler Club Advertise on the podcast or in the newsletter: citycast.fm/advertise

Is caffeine actually good for you? Learn from Stephen Cherniske, author of 'Caffeine Blues' as we dive into the secrets behind coffee, DHEA, cortisol, and saffron for anxiety!New episodes of Welcome to Wellness released every Friday!Hyperlinked show notes at https://www.ashleydeeley.com/w2w/caffeine

AP correspondent Ed Donahue reports on a White House plan to lower drug prices.

What happens to medications after they leave the pharmacy?   In this episode of The Pharmacist's Voice Podcast, Ohio pharmacist Kim Newlove discusses why and how pharmacists should incorporate drug disposal education at prescription pick-up—before medications become a safety risk in the home.   Kim shares two practical approaches: Passive education, such as signage at the pharmacy counter Direct education, through brief counseling conversations   Read the FULL show notes on https://www.thepharmacistsvoice.com/podcast   You'll also hear a real-world example of how pharmacists and students can make a long-term community impact by creating and maintaining county-wide drug take-back box lists.   In this episode, you'll learn: Why "beginning with the end in mind" matters in pharmacy workflow What information to include on a drug disposal sign at the pick-up window How to counsel patients on drug disposal without adding burden to your day Why drug take-back boxes and events are critical for safety, diversion prevention, and environmental protection Seven benefits of proper medication storage and disposal How pharmacists and student pharmacists can support community-wide prevention efforts   This episode is ideal for pharmacists, student pharmacists, preceptors, and pharmacy leaders looking for realistic ways to improve patient education and public health outcomes.   Helpful Links & Resources: DEA National Drug Take Back Program: https://www.dea.gov/takebackday  FDA Flush List: https://www.fda.gov/drugs/disposal-unused-medicines-what-you-should-know/drug-disposal-fdas-flush-list-certain-medicines Wood County, Ohio Drug Take-Back Box List: https://www.wcadamh.org/guides    Share This Episode If you know a pharmacist or student pharmacist who works at the prescription pick-up window, please share this episode with them.    Follow the show Subscribe to or follow The Pharmacist's Voice® Podcast on your favorite podcast player and on YouTube so you never miss a new episode.    Additional content - not mentioned in this episode At most, there are 6 weekly episodes after episode 361. This is what's coming up:  Ep 362: December 26, drug pronunciation episode  Ep 363: January 2, Faith Community Discussions about Addiction + Justice  Ep 364: January 9, drug pronunciation episode Ep 365: January 16, Moneyball 2.0 Ep 366: January 23, 6 Year Podcast Anniversary Show Ep 367: January 30, possible bonus with Vance Brown, RPh   Sign up for The Pharmacist's Voice ® monthly email newsletter! https://bit.ly/3AHJIaF    This podcast is on all major podcast players and YouTube. Popular links below. ⬇️   Apple Podcasts   https://apple.co/42yqXOG  Spotify  https://spoti.fi/3qAk3uY  Amazon/Audible  https://adbl.co/43tM45P YouTube https://bit.ly/43Rnrjt   Host Background: Kim Newlove has been an Ohio pharmacist since 2001 (BS Pharm, Chem Minor). Her experience includes hospital, retail, compounding, and behavioral health. She is also an author, voice actor (medical narrator and audiobook narrator), podcast host, and consultant (audio production and podcasting).    Kim's websites and social media links: ✅ Guest Application Form (The Pharmacist's Voice Podcast) https://bit.ly/41iGogX ✅ Monthly email newsletter sign-up link https://bit.ly/3AHJIaF  ✅ LinkedIn Newsletter link https://bit.ly/40VmV5B ✅ Business website https://www.thepharmacistsvoice.com ✅ Get my FREE eBook and audiobook about podcasting ✅ The Pharmacist's Voice ® Podcast https://www.thepharmacistsvoice.com/podcast ✅ Drug pronunciation course https://www.kimnewlove.com  ✅ Podcasting course https://www.kimnewlove.com/podcasting  ✅ LinkedIn https://www.linkedin.com/in/kimnewlove ✅ Facebook https://www.facebook.com/kim.newlove.96 ✅ Twitter https://twitter.com/KimNewloveVO ✅ Instagram https://www.instagram.com/kimnewlovevo/ ✅ YouTube https://www.youtube.com/channel/UCA3UyhNBi9CCqIMP8t1wRZQ ✅ ACX (Audiobook Narrator Profile) https://www.acx.com/narrator?p=A10FSORRTANJ4Z ✅ Start a podcast with my coach, Dave Jackson from The School of Podcasting! *New 12-4-25* Click my affiliate link: https://community.schoolofpodcasting.com/invitation?code=G43D3G    Thank you for listening to episode 361 of The Pharmacist's Voice ® Podcast.  If you know someone who would like this episode, please share it with them!

Dive into the surprising and often dangerous world of psychoactive substances and our furry friends. This episode explores historical animal experiments with drugs like LSD and psilocybin, real-life cases of accidental pet poisonings from marijuana, amphetamines, and more, veterinary insights on toxicity risks, and why giving psychedelics or recreational drugs to dogs and cats is never a good idea—highlighting symptoms, treatments, and safer alternatives.▶️ *[WORK WITH ME]* https://RobbJarrett.net▶️ *FREE* Personal Brand Starter Kit :: https://www.medialabb.net/brandkit*[SUBSCRIPTIONS I RECOMMEND]*ABOBE CREATIVE SOFTWARE - VIDIQ (AI Creation and SEO) - https://vidiq.com/robbjarrett Motion Array (Assets) - Envato (Assets) - OPENART (AI Creation Tools)BEACONS: https://beacons.ai/signup?c=robbjarrett*[PRODUCTS I RECOMMEND]*SM7B Microphone - https://amzn.to/47AuKREMV7+ Microphone - https://amzn.to/3V7LRmABLUE YETI Microphone - https://amzn.to/3V7LRmAOBSBOT Webcam - https://amzn.to/4mcWhMFDJI Action Cam - https://amzn.to/3V44gk7DJI OSMO Gimbal - https://amzn.to/3V44gk7NEEWER Lights - https://amzn.to/4pfvMJe

In episode 1982, Jack and Miles are joined by host of Go Home Bible, You're Drunk and White Homework, Tori Williams Douglass, to discuss… Vivek Ramaswamy - The Boy Who Thought The Racists Would Accept Him…, Trump Plays WMD Card In War On “Drugs", Okay...The Grinch Is Officially Ruined and More! Vivek Ramaswamy goes to a Turning Point USA event in Ohio and quickly finds out that he is not on the team. What Is an American? Trump declares fentanyl a 'weapon of mass destruction' with executive order The US is already at war with Venezuela Jon Stewart Likens U.S. Aggression Toward Venezuela To Iraq In The 2000s: “Saddest Part … Is That Dick Cheney Won’t Be Around To See It” U.S. Overdose Deaths Decrease Almost 27% in 2024 What’s behind the significant drop in opioid overdose deaths CDC Reports Nearly 24% Decline in U.S. Drug Overdose Deaths Exclusive: Trump team withholds $140 million budgeted for fentanyl fight Trump Administration Proposes Defunding Federal Narcan Distribution Program Trump administration praised ‘life-saving’ naloxone, then proposed cuts Trump Signs Law to Unlock Billions for Drug Addiction Recovery Charted: Shifts in America's leading causes of death Trump administration shuts down LGBTQ youth suicide hotline NIH Funding Cuts Disrupt Clinical Trials, Affecting 74,000 Participants White House uses 'Grinch' poster and quote to criticize Democrats on healthcare policies Trump’s Education Goon Releases Ultra-Cringe ‘Christmas’ Video How Dr. Seuss Gave Us One of the Most Complex, Socially Important Heist Stories Ever Walmart Serves Walton Goggins as The Grinch To Warm Up Black Friday Welcome to the Grinchʼs Walmart The Grinch is more popular than ever. There's a new McDonald's meal and tons of Christmas merch. Here's why it happened. Why the 'dank, eerie, weird' Grinch movie became a millennial Christmas classic How How the Grinch Stole Christmas Stole Christmas LISTEN: Wandering by Oscar PetersonSee omnystudio.com/listener for privacy information.

Join Jim and Greg for the Wednesday 3 Martini Lunch as they unpack Sen. John Fetterman's clarification on U.S. strikes against Venezuelan drug boats, wince at House Republicans helping Democrats push an Obamacare subsidy extension, and vent over the deeply troubling conduct of police and politicians in the Brown University shooting investigation. First, they respond […]

If you've got a penicillin allergy, this episode is crucial for you! That's because you can outgrow a drug allergy like this even if you developed it as an adult. Antibiotic allergies are either misdiagnosed or fade over time. Even if you avoid taking antibiotics like the plague, having a drug allergy on your medical chart can end up limiting treatment options if you find yourself truly needing them.In this episode, my guest, Dr. Mariana Castells, breaks down how drug allergies are diagnosed, how long they take to disappear, why they can appear later in life, and how “drug delabeling” could dramatically improve your care (especially when something serious happens). Dr. Mariana Castells, M.D., Ph.D., is a world-renowned expert in allergy and immunology with over 30 years of experience. Whether you have an antibiotic allergy (or you know someone who does), this is a must-listen interview!⭐️Mentioned in This Episode:- See all the references

In February 2025, Kristin and James Brock were found shot to death in their bed in Carroll County, Georgia. Their five-year-old daughter discovered the bodies. Their teenage daughter, Sarah Grace Patrick, called 911. For months, Sarah posted tearful TikToks mourning her parents, gave an emotional eulogy at their funeral, and reached out to true crime influencers asking them to cover the case. She commented on videos speculating about who the killer might be. She allegedly wrote that the media coverage "would be a really big hit." Then investigators arrested her for both murders. Sarah Grace Patrick was sixteen when her mother and stepfather were killed. She's now seventeen, charged as an adult with two counts of murder, two counts of malice murder, and multiple weapons charges. She's being held without bond in the Carroll County Jail, awaiting trial set for January 2026. But this case goes deeper than a teenager's social media activity. Years before the killings, Sarah was caught in a bitter custody battle between her biological parents. At eleven years old, she told police she felt unsafe in her mother's home and begged a court to let her live with her father. Drug allegations. A dropped assault accusation. A blended family with a complicated history. Now the community is divided. Supporters wearing "I Stand with Sarah" shirts packed the courtroom at her bond hearing. The victims' family begged the judge to keep her locked up, fearing for their own safety. Her grandfather insists she's innocent. Investigators say they have "mountains of evidence." No motive has been disclosed. The murder weapon was never found. And the youngest victim in this case — the six-year-old who found her parents' bodies — may have to testify against her own sister. #SarahGracePatrick #TrueCrime #CarrollCounty #KristinBrock #JamesBrock #GeorgiaCrime #TikTokMurder #CourtTV #MurderTrial #JusticeForKristinAndJames Want to comment and watch this podcast as a video? Check out our YouTube Channel. https://www.youtube.com/@hiddenkillerspod Instagram https://www.instagram.com/hiddenkillerspod/ Facebook https://www.facebook.com/hiddenkillerspod/ Tik-Tok https://www.tiktok.com/@hiddenkillerspod X Twitter https://x.com/tonybpod Listen Ad-Free On Apple Podcasts Here: https://podcasts.apple.com/us/podcast/true-crime-today-premium-plus-ad-free-advance-episode/id1705422872

In February 2025, Kristin and James Brock were found shot to death in their bed in Carroll County, Georgia. Their five-year-old daughter discovered the bodies. Their teenage daughter, Sarah Grace Patrick, called 911. For months, Sarah posted tearful TikToks mourning her parents, gave an emotional eulogy at their funeral, and reached out to true crime influencers asking them to cover the case. She commented on videos speculating about who the killer might be. She allegedly wrote that the media coverage "would be a really big hit." Then investigators arrested her for both murders. Sarah Grace Patrick was sixteen when her mother and stepfather were killed. She's now seventeen, charged as an adult with two counts of murder, two counts of malice murder, and multiple weapons charges. She's being held without bond in the Carroll County Jail, awaiting trial set for January 2026. But this case goes deeper than a teenager's social media activity. Years before the killings, Sarah was caught in a bitter custody battle between her biological parents. At eleven years old, she told police she felt unsafe in her mother's home and begged a court to let her live with her father. Drug allegations. A dropped assault accusation. A blended family with a complicated history. Now the community is divided. Supporters wearing "I Stand with Sarah" shirts packed the courtroom at her bond hearing. The victims' family begged the judge to keep her locked up, fearing for their own safety. Her grandfather insists she's innocent. Investigators say they have "mountains of evidence." No motive has been disclosed. The murder weapon was never found. And the youngest victim in this case — the six-year-old who found her parents' bodies — may have to testify against her own sister. #SarahGracePatrick #TrueCrime #CarrollCounty #KristinBrock #JamesBrock #GeorgiaCrime #TikTokMurder #CourtTV #MurderTrial #JusticeForKristinAndJames Want to comment and watch this podcast as a video? Check out our YouTube Channel. https://www.youtube.com/@hiddenkillerspod Instagram https://www.instagram.com/hiddenkillerspod/ Facebook https://www.facebook.com/hiddenkillerspod/ Tik-Tok https://www.tiktok.com/@hiddenkillerspod X Twitter https://x.com/tonybpod Listen Ad-Free On Apple Podcasts Here: https://podcasts.apple.com/us/podcast/true-crime-today-premium-plus-ad-free-advance-episode/id1705422872

War Room Brown University Shooting May Be Linked To MIT Professor's Murder, Dems Release More Epstein Photos & Trump Downgrades Marijuana Drug Classification

That speech wasn't just good — it was strategic. Tara breaks down why Donald Trump's tightly focused, 18-minute address may be one of the most important speeches heading into the midterms. From crushing prescription drug prices to exposing massive health care fraud tied to Obamacare, insurance companies, and illegal immigration, Trump finally said out loud what most Americans never hear — because if you don't listen to talk radio, you have no idea what was done to this country. This episode explains the corruption, the incentives, and why repeating this message every single day could change everything.

Thousands of Americans die each year after overdosing on illicit synthetic drugs, including synthetic opioids like fentanyl. Transnational criminal organizations have played a central role in fueling this health crisis here in the United States. In…

A next generation factory has been in space since 2012. Elon Musk is just starting to develop drugs in space with StarFall.  What if the most revolutionary pharmaceutical factory wasn't in New Jersey—but 250 miles above your head?   What if your next cancer drug was manufactured in orbit and delivered to your living room? Israeli scientist Yossi Yamin reveals how Space Pharma, since 2012, has been crystallizing medicine in microgravity—creating treatments impossible on Earth.   In this mind-bending episode, we sit down with Yossi Yamin, founder of Space Pharma, the Israeli company that's literally manufacturing medicine in orbit. And no, this isn't science fiction. It's happening right now.  Large variety of life science experiments can be conducted in miniaturized, A remotely controlled fully automated labs based on a lab-on-a-chip (LOC) technology.Here's what sounds impossible but isn't:→ Cancer patients receiving treatments at home instead of hospitals—every 6 weeks instead of every 2 weeks→ Drug crystals forming in microgravity that cannot physically exist on Earth→ Human tissue organoids growing in space to test personalized medicine on YOUR cells before you take a single dose→ Bacteria battles conducted from ground control to defeat superbugs without antibiotics→ Europe's first orbital pharmaceutical factory producing millions of doses per year by the early 2030sThe secret? Crystallization. #Podcast #Science #Medicine #Technology #Innovation #SpaceTech #Healthcare #Biotech  #SpacePharma #IsraeliInnovation #PersonalizedMedicine #CancerResearch #Pharmaceuticals #MedicalBreakthrough #SpaceManufacturing #StartupNation https://pod.link/1585604285https://findinginspiration.substack.com/

Dr. Christina Smolke runs a brewery, except the yeast isn't making alcohol. It's making medicine. At Antheia, Smolke has turned a long-shot Stanford research project into a new way to manufacture critical pharmaceutical ingredients, using biology instead of traditional chemistry.The approach is already being used to produce opioid precursors for Narcan, with more drugs in the pipeline aimed at chronic shortages and supply-chain failures. Smolke talks about regulation, security, and why some of the hardest problems in science are worth chasing—especially when everyone says they won't work. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

AP Washington correspondent Sagar Meghani reports on President Trump signing an executive order labeling marijuana a less dangerous drug.

Scoot talks about President Trump signing an executive order classifying marijuana as a Schedule 3 drug, the San Antonio family fined $2,500 by their Homeowners Association for decorating their home like the Griswolds from "Christmas Vacation," and Tucker Carlson's failed prediction that President Trump will announce war with Venezuela during his speech.

Scoot talks about the positives of President Trump signing an executive order classifying marijuana as a Schedule 3 drug. Then, Kevin Todd of thesportsbrokers.com joins Scoot to give his football predictions for this week.

"70 million Americans have criminal records." Connect With Our SponsorsGreyFinch - https://greyfinch.com/jillallen/A-Dec - https://www.a-dec.com/orthodonticsSmileSuite - https://getsmilesuite.com/ Summary In this conversation, Jill Allen and David Harris discuss the critical aspects of hiring practices in orthodontic practices, focusing on how to prevent embezzlement and ensure a safe working environment. They delve into the importance of pre-employment screening, criminal background checks, drug testing, and social media scrutiny. The discussion also covers the significance of dividing duties among team members to mitigate risks, the challenges posed by electronic payments, and the necessity of financial oversight. David emphasizes the need for practice owners to be proactive in safeguarding their practices against potential fraud and to maintain clear communication with their teams. Connect With Our Guest Prosperident - https://www.prosperident.com/ Takeaways Hiring practices should focus on preventing the wrong hires.70 million Americans have criminal records, making background checks essential.Drug testing is becoming easier and should be a standard practice.Social media can reveal a lot about a candidate's character.Dividing duties among team members can significantly reduce embezzlement risk.Electronic payments are easier to divert than physical payments.Regularly reconcile collections with bank deposits to catch discrepancies.Practice owners should print their own financial reports for accuracy.Discrepancies should be investigated through documentation, not just staff explanations.Chapters 00:00 Introduction01:47 Reintroducing David Harris and His Work03:00 The Importance of Hiring Right04:41 Pre-Employment Screening Essentials05:20 Criminal Records and Background Checks07:36 Talking to Former Employers09:05 Drug Testing and Social Media Checks13:41 Legal Considerations in Hiring18:57 Dividing Duties to Prevent Embezzlement26:47 Digital Payments and Fraud Risks28:32 Preventing Employee Theft31:16 Reconciling Payments and Deposits34:44 Ensuring Financial Integrity41:39 Final Thoughts and Contact InformationEpisode Credits:  Hosted by Jill AllenProduced by Jordann KillionAudio Engineering by Garrett LuceroAre you ready to start a practice of your own? Do you need a fresh set of eyes or some advice in your existing practice?Reach out to me- www.practiceresults.com.    If you like what we are doing here on Hey Docs! and want to hear more of this awesome content, give us a 5-star Rating on your preferred listening platform and subscribe to our show so you never miss an episode.    New episodes drop every Thursday!   

This week, Kelly Carlin joins the show to talk about how smartphones hijack attention, cause "digital brain fog," and displace real human connection. Kelly, and our host Rosie Tran, share some recommendations on what to do about it. Nobody should control how your mind functions. Not even that weird caterpillar from the Shazam movie. Learn more at https://www.stupidsexyprivacy.com

Ron Lanton III, Esq, joined Over the Counter to discuss the Most Favored Nation drug pricing policy and what exactly it may mean for stakeholders heading into 2026.

Ad Free Dopey:www.patreon.com/dopeypodcastIn this crucial emergency episode, Dave is joined by longtime friend and recovery legend Bob Forrest to process the shock, grief, and fallout surrounding the Nick Reiner tragedy and the public backlash aimed at Dopey.Bob speaks from decades of experience in addiction treatment, psychiatry-adjacent crisis work, and firsthand encounters with drug-induced psychosis, violence, and untreated mental illness. He explains why modern drugs—especially meth and stimulants—are producing homicidal and suicidal behavior, and why families often have no remaining safety net when things spiral.They discuss:Why parents can love their children and still need boundaries, charges, or interventionHow decriminalization + lack of psychiatric resources leaves families helplessWhy people project their own trauma and rage onto public figures and podcastsThe danger of separating “mental health” from active addictionCelebrity kids, resentment, identity, and why some survive while others don'tWhy Dopey is being scapegoated—and why that logic doesn't hold upThe conversation moves through music, recovery, punk rock, famous addiction stories, Christmas memories, suicidal ideation, parenting, and connection, ultimately landing on Bob's central belief: connection, love, truth, and honesty are what keep people alive.The episode ends with Bob defending Dopey's right to tell the whole truth about addiction—ugly, funny, painful, and real—and offering a blunt but heartfelt holiday message to Dopey Nation. All that and more on this brand new Wednesday episode of the good old Dopey show.  Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Join Jim and Greg for the Wednesday 3 Martini Lunch as they unpack Sen. John Fetterman's clarification on U.S. strikes against Venezuelan drug boats, wince at House Republicans helping Democrats push an Obamacare subsidy extension, and vent over the deeply troubling conduct of police and politicians in the Brown University shooting investigation.First, they respond to Sen. Fetterman's explanation that U.S. intelligence on the Venezuelan drug boats is clear and comprehensive, with American officials knowing exactly who and what is on board. Jim argues that President Trump's national security team should declassify as much of this information as possible so the public can hear the facts directly.Next, they groan as four House Republicans sign a discharge petition forcing a vote on the Democrats' Obamacare subsidy extension bill. If it passes, pressure will immediately shift to Senate Republicans to follow suit. Jim questions what the point of the shutdown fight was if this is the inevitable outcome, while Greg asks why Republicans in competitive districts can't offer a stronger alternative instead of aligning with Democrats.Finally, they react to the latest, deeply unreassuring statements from officials overseeing the Brown University shooting investigation. Authorities refuse to say what students told them the shooter said before opening fire and are openly scolding reporters for asking questions they don't like.Please visit our great sponsors:Try Quo for free at https://Quo.com/3ML and keep your existing number—Quo means no missed calls, no missed customers.Give your liver the support it deserves with Dose Daily.  Save 35% on your first month when you subscribe at https://DoseDaily.co/3ML or enter code 3ML at checkout. Stop putting off those doctors' appointments and go to https://ZocDoc.com/3ML to find and instantly book a top-rated doctor today.New episodes every weekday. 

Andy starts with Jayden Daniels' first comments since being shut down for the season. (17:45) Is Phil Rivers inspiring other alte kaker QBs to come out of retirement? (34:50) More from around the NFL, including Joe Burrow's mid career crisis in Cincy. To hear the whole show, tune in live from 9:00 AM - 11:00 AM Monday-Friday. For more sports coverage, download the ESPN630 AM app, visit https://www.sportscapitoldc.com. To join the conversation, check us out on twitter @ESPN630DC and @andypollin1See omnystudio.com/listener for privacy information.

TOPICS: Nick Reiner Arrested US Strikes 3 Drug Boats DC Chief Pamela Smith Coffee Talk with David Eon (LIVE WEEKDAY DAILY NEWS TALK) for Tuesday, December 16th, 2025

Drug smugglers are now using cows as a means to transport cocaine and bring drugs into Europe from Latin America. This method is being favoured by cartels knowing that International law enforcement agencies will be reluctant to search cattle ships…Max Stephens, International Crime Correspondent for the Daily Telegraph has been investigating this, and joins Seán to discuss.

Senator Eric Schmitt of Missouri, who serves on the Judiciary Committee and chairs the Subcommittee on the Constitution, joined The Guy Benson Show today to discuss the Trump administration's strikes against drug boats in the Caribbean and Latin America, pushing back on Democratic criticism by explaining why the actions are both legal and necessary. Schmitt also addressed the administration's renewed foreign policy focus on the Western Hemisphere and putting America first, targeting drug cartels and the opioid crisis at home, along with the bipartisan congressional briefings held to share intelligence and details surrounding the strikes. Senator Schmitt then weighed in on the importance of appointing and confirming Trump's judicial nominees, and outlined the Republican approach to healthcare reform. Listen to the full interview below! Learn more about your ad choices. Visit podcastchoices.com/adchoices

December 16, 2025Have you had your dose of The Daily MoJo today? Download the APP HERE"Ep 121625: Dead & Gay | The Daily MoJo"Ella Cook's incident raises concerns about campus surveillance and investigations. The conversation also covers Kyle Rittenhouse's marriage and the cultural significance of General Hospital. Drug classification, particularly marijuana's Schedule One status, is examined alongside its health impacts compared to alcohol. A dialogue between a parent and teacher addresses school safety for LGBTQ+ students and immigration issues. The discussion concludes with reflections on societal changes and the complexities of cultural integration.Phil Bell's Morning Update - Kamala is a consequence:  HEREAllThingsTrains.comAll American Talk ShowAllThingsTrainsPhil on X: HEREDan Andros - host of The QuickStart Podcast and Managing Editor at CBN.com - Is on vaca but still showed up to rant!FaithwireCBN NewsYouTubeOur affiliate partners:EMP Shield - Figuring out the odds of a devastating EMP attack on the United States is impossible, but as with any disaster, the chances are NOT ZERO, and could happen any day. This decade has proven that the weird and unexpected is right around the corner. Be prepared - protect your home, vehicle, even your generator - with EMP Shield. You'll save money and protect what's important at the same time!ProtectMyMoJo.com Be prepared! Not scared. Need some Ivermection? Some Hydroxychloroquine? Don't have a doctor who fancies your crazy ideas? We have good news - Dr. Stella Immanuel has teamed up with The Daily MoJo to keep you healthy and happy all year long! Not only can she provide you with those necessary prophylactics, but StellasMoJo.com has plenty of other things to keep you and your body in tip-top shape. Use Promo Code: DailyMoJo to save $$Take care of your body - it's the only one you'll get and it's your temple! We've partnered with Sugar Creek Goods to help you care for yourself in an all-natural way. And in this case, "all natural" doesn't mean it doesn't work! Save 15% on your order with promo code "DailyMojo" at SmellMyMoJo.comCBD is almost everywhere you look these days, so the answer isn't so much where can you get it, it's more about - where can you get the CBD products that actually work!? Certainly, NOT at the gas station! Patriots Relief says it all in the name, and you can save an incredible 40% with the promo code "DailyMojo" at GetMoJoCBD.com!Romika Designs is an awesome American small business that specializes in creating laser-engraved gifts and awards for you, your family, and your employees. Want something special for someone special? Find exactly what you want at MoJoLaserPros.com  There have been a lot of imitators, but there's only OG – American Pride Roasters Coffee. It was first and remains the best roaster of fine coffee beans from around the world. You like coffee? You'll love American Pride – from the heart of the heartland – Des Moines, Iowa. AmericanPrideRoasters.com   Find great deals on American-made products at MoJoMyPillow.com. Mike Lindell – a true patriot in our eyes – puts his money where his mouth (and products) is/are. Find tremendous deals at MoJoMyPillow.com – Promo Code: MoJo50  Life gets messy – sometimes really messy. Be ready for the next mess with survival food and tools from My Patriot Supply. A 25 year shelf life and fantastic variety are just the beginning of the long list of reasons to get your emergency rations at PrepareWithMoJo50.comStay ConnectedWATCH The Daily Mojo LIVE 7-9a CT: www.TheDailyMojo.com Rumble: HEREOr just LISTEN:The Daily MoJo ChannelBecome a supporter of this podcast: https://www.spreaker.com/podcast/the-daily-mojo-with-brad-staggs--3085897/support.

Retatrutide is years away from FDA approval and yet the fight over access, price, control of this medication is already well underway. That's what this podcast is going to be about today. There's well over a hundred thousand people by my estimates who are already on some form of this medication today. And that should tell you enough about how disruptive this molecule is and will be. It is a game changer among game changer. We've been talking about it for three years here at On The Pen, well before any of your favorite gym bros were talking about Retatrutide. We were talking about Reta, who tried Retatrutide here at On The Pen. And that's because we identified this triple agonist as a game changer among game changers. So This is going to be a very Retatrutide heavy episode, and so I hope you'll join us and stick with us if this is a topic you enjoy, because I think this is really going to effectively lay the groundwork for what accessibility to this medication will look like. So let's get into it. Welcome to the On The Pen Podcast with your host, Dave Knapp. Welcome to the On The Pen, the weekly dose podcast. This is our weekly roundup in incretin memetic news. And frankly, there's no news that is bigger than Reta-Trutide news. Just find me any news that is bigger than the data that we got on Reta-Trutide. Now, we already did a video about the Triumph Phase II clinical trials that we got in osteoarthritis of the knee. You can go back and check out that video if you'd like more data. So we're not gonna super... rehash the data. We'll go over at a high level what the data showed us. We're not going to go over how the medicine works, because by now we all know that it's the triple agonist, right? If terzapatide was a dual agonist, GLP-GIP, Retatrutide is the triple agonist that adds to it a glucagon component, which is absolutely just shredding, shredding liver fat. It is absolutely revving up people's metabolism and showing a tremendous amount of weight loss. So let's get into what the weight loss looked like in this first trial, because there are longer obesity trials where, where the primary outcome is the weight loss this was again a specific trial in measuring pain reduction in folks with osteoarthritis of the knee but check out these numbers these are placebo adjusted meaning it's taking the two percent out that people lost on placebo but looking at these numbers Folks on one milligram over forty eight weeks lost seventeen percent. They bumped up to four milligrams. Those folks lost twenty two percent. So right there at the lowest dose, you're already reaching the efficacy of today's drugs that are on the market, like triseptide and semaglutide in their various forms. If you bumped up to eight milligrams, you saw twenty four percent placebo adjusted weight loss and at twelve milligrams, twenty six point four percent weight loss. Adding back in that two percent of the placebo that those on placebo loss, that's twenty eight point four percent weight loss in these forty eight weeks at the highest dose. When you adjust for some of the more real world outcomes, you kind of ding the numbers a little bit based upon people who quit the drug, et cetera. Those numbers look more like a twenty percent weight loss and twenty three point seven percent weight loss at the highest dose. But even then, you're still seeing a drug that is better than the current drugs that are on the market. around forty eight percent of patients on Retatrutide lost greater than twenty five percent. And then if you were at that twelve twelve milligram dose, that highest dose patients lost fifty nine percent of patients lost more than twenty five percent of their body weight. There was a subset that lost thirty percent of their body weight and some even over thirty five percent of their body weight on Retatrutide. So the lower doses compete with today's best drugs and the upper doses are entering into bariatric surgery level weight loss. And that's putting the whole obesity system on notice and probably a lot of surgeons nervous because typical body weight loss was something like the street sleeve gastrectomy. For example, it's about eighteen to twenty five percent body weight. The Roux-en-Y gastric bypass twenty five to thirty five percent weight loss or the duodenal switch thirty to forty percent weight loss. So the upper doses of Ritutrutide overlap with sleeve and bypass outcomes without any surgery. It's incredible. It is a game changer among game changer. It is the new benchmark in obesity medicine. And there's actually more data, like I said, landing in later twenty twenty six. The longer duration will historically, if history is a marker, equal more weight loss than we even see here at this forty eight weeks. We have an interview that will be airing later this week on our channel and on our podcast with our friend Mimi from Australia who just wrapped up her clinical trial on Retatrutide. They ended it like ten weeks early on her, which was a huge bummer to her. So we're going to hear from her because she had to end abruptly. We're going to hear her story, an incredible story. She's one of those folks that got up that thirty five percent body weight loss in the time that she was on Retatrutide. So, this is just showing you that these drugs are not simply an alternative to bariatric surgery. We are approaching a point in time where these are on par with bariatric surgery, and as people are on this Reta-Trutide trial, you see that these numbers aren't plateauing either. So we will see stronger weight loss numbers the longer that these folks are on this trial. And I think you'll see some of those numbers in that population of folks on the higher doses eclipse maybe even some of what we see with some of these bariatric surgeries. the real story that i think is taking shape here is not in how powerful Retatrutide is because we've literally been expecting or anticipating this kind of data for more than three years at on the pin we've been talking about this and i think that's sort of reflected in the fact that you didn't see this massive spike in eli lilly stock wall street was expecting this as well Um, so it was on par, I think with expectations, but the expectations are astronomical compared to previous options that were available to patients and all the innovation in the world. All of these drugs, we talked at last week about WV, E double Oh seven, the James Bond of weight loss that targets fat, not only targets fat loss, but it also targets the promotion of building of, of lean muscle mass. We're talking about an insane future in obesity medicine. But none of it means anything if people can't access it. And that's really where we are today in terms of ensuring that there's going to be an option for everyone. And that's sort of what I want to get into today, because Lilly wants Retatrutide to be classified as a biologic, so not a traditional small molecule drug like you've seen every other incretin and nutrient-stimulated hormone-treating obesity on the market to date. They're trying to get this classified as a biologic. Now, we talked about this before on the podcast. That matters in three major ways. It affects the exclusivity length of time that a pharmaceutical company has on a drug. That goes from, I believe, five years of market exclusivity to twelve. It affects compounding rules because biologics cannot be compounded. And then that gives the pharmaceutical companies a tremendous amount of pricing power in the marketplace, because essentially there's no competition and there's no competition for a long time. But this whole argument about getting this classified as a biologic is not about safety. It's about protection and we're going to get into it. So let's explain this here. This is why Retatrutide really is not a biologic arguably. So biologics are large proteins. There are hundreds of or even thousands of amino acids grown in living cells that are sensitive to tiny manufacturing changes. Retatrutide is a short chain peptide. It's chemically synthesized and it is below the traditional biological size thresholds when it comes to how those things are defined. We'll just leave it at that. So even though it acts like a biologic in the body, it's made like a drug. It's made like a small molecule drug. And if it's treated as a drug, they get, like I said, five years of market exclusivity. Now, really a lot of confusion around what this means, but essentially the first five years of the life of a drug, the patent can be challenged for a number of reasons. We've seen patent challenges right now are going on in the courts for both semaglutide and terzepatide. But these companies are guaranteed that five years of market exclusivity, no matter how those patent lawsuits shake out. That five years jumps to twelve years with the biologic. So ultimately, there's no biosimilars that are allowed during that twelve year window. Again, with terzapatidin and semaglutide, it's five years. They could lose their market exclusivity within five years of the release of the patent. twelve years with a biologic. So if they lose their patent challenges on Trezabitide, they still have some time left with market exclusivity for the drug. They likely will not lose those, but that jumps to twelve years. And I think the most important thing to understand about the reclassification of Reta-Trutide to a biologic would mean that, 503A and 503B pharmacies are effectively locked out of compounding this medication, 503Bs would have some latitude arguably, but they would face extreme barriers. Routine compounding becomes legally and technically restricted because biological status doesn't slow compounding down. It actually shuts the door or almost completely shuts the door. Biologics not only would allow Lilly to have longer market exclusivity, no compounding, but it would allow them to command a higher price in the marketplace because A, they get this designation and there's an assumption when they bring this to market that they're harder to manufacture, that they're harder to copy, that there are fewer negotiating alternatives for payers. They can command a higher price with the insurance companies, and the price pressure stays muted for much longer because, again, you don't have those pressures of compounding. You don't have the pressures externally from lawsuits that could end your market exclusivity in that first five years of the drug's existence. So there's just a lot of price pressure upwards on a biologic compared to a normal small molecule drug. And when there's no credible alternative or backup option, which to Retatrutide, there wouldn't be, it'd be the first drug that has bariatric surgery level results. The prices won't come down. They'll command a massive price and the prices won't come down. So let's talk about where this currently stands because ultimately the Eli Lilly went to the FDA. We've been covering this for well over a year, maybe close to two years now, a year and a half at least. Lily went to the FDA, they said, we want this classified as a biologic, here are the reasons why. The FDA initially said, no, we're not gonna do that. So Lily challenged that decision in court. So the point that we're at today is the court told the FDA to reconsider and better explain itself So the first no given to the FDA to Lilly didn't stick. The courts looked at it and they said, you need a better, you need to reconsider your decision and you need to explain your decision better to Lilly. So ultimately we're sitting now at the point where the court has made its decision that the FDA has to go back and now we await basically what the FDA has to say on this. But if this thing is classified as a biologic, that would be a massive massive loss for patients. Now, again, we're, we're focusing on the accessibility of this drug into the future. And, and I think that this is an important conversation to have. One of the interesting points that I have to bring into the conversation is the fact that I got to sit in on a, on a closed session question and answer with the media. I didn't get to answer or, excuse me, excuse me, ask a question at this time, but shortly after the most favored nations announcement, with eli lilly and the trump administration in the oval office that day there was a press briefing that i was invited to dave ricks was asked by max bayer reporter of endpoints who we've interviewed here on this very podcast and he was asked was Retatrutide included in the most favored nations discussions meaning will we get a cash pay version of Retatrutide uh that is you know circumventing the pbms uh will we get these cheaper prices will will it be be two hundred fifty dollars also and there was a hard no there was a hard no like no that was not included that was not part of these discussions even though what we heard from the trump administration was that those these companies that were jumping on to the most favored nations agreement were also agreeing to offer future drugs at most favored nations pricing now was lily saying that no they're not going to offer it at the it wasn't part of the negotiations in terms of the price points that they had discussed for triseptide maybe or did it mean altogether there won't be a cash pay option of this medication i don't know um that we would love to get clarity on But I highly doubt we're going to get any more information than necessary at this point in time. So, Reta-Trutide is being positioned to be a drug that, and well so, should be offered at a premium. This is a drug that is far exceeding the current drugs that are on the market. I think that we're gonna see even the indications of Reta-Trutide far beyond simple obesity, but it is going to be their crown jewel for the next decade, more than likely. Reta-Trutide is going to be a massive drug, and so they're attempting to build a moat around it. And these are things that we need to be aware of as a community so that we can hold our positions and conversations about these and basically, you know, be able to articulate to people in positions of power like this is an important thing to us. This is an important thing in the advocacy of obesity and sort of the next frontier of the fight of accessibility, which marches on. each and every day because of course the current drugs, while as great as they are and as much as access is expanding, there are still people with sicker or rather more advanced versions of metabolic disease that are gonna need these newer treatments and price is going to be a huge factor. So let's talk about the gray market right now because I think it's also nearly impossible to talk about this topic without including a discussion about the gray market because there are, as I mentioned at the outset, hundreds of thousands of people on this medication already. So research grade Retatrutide exists. It's in the gray markets of the Internet. It's where people are going and they're buying, you know, basically versions of these these peptides that are made in factories overseas. They're being imported into the United States, oftentimes illicitly in shipments that are marked as something else. The FDA has tried to crack down. There's no doctor involved in this. It's a very, that's why it's called the gray market, right? So it's not a prescription medicine, but the demand for this is massive. And all you have to do is really scroll your TikTok for about fifteen minutes. You're going to come across a insane amount of content on the topic of Retatrutide. An insane amount of, and oftentimes, you know, what I find most disturbing is oftentimes it looks like very young people. very young people taking Retatrutide. Crazy, it's crazy. But the demand is massive and there's a whole gray market for it proliferating over on TikTok and in the far reaches of the internet. And I would estimate that tens, if not hundreds of thousands of people are already or have already used it. And I think it's a testament to a to to the effectiveness of this drug. It's also a testament to the fact that there needs to be more guardrails, I think, around this stuff than there currently is, because gray markets appear and they thrive when legal access lags the reality of the demand for the medication. And you saw this earlier this week as we launched a petition to fight back against the Safe Drug Act of twenty twenty five, a drug, a drug act that is in theory designed to put guardrails around compounding. But in practice, I think is creating a new battlefield for Eli Lilly and Novo Nordisk to shut down compounding on the current classes of medications, which is why We as a community need to be loud about our opposition to it. If they were really concerned about the safety of compounds, they would do two very simple things. They would require reporting around the active pharmaceutical ingredient of a compound. Patients ought to be able to know where the actual source of their medication is coming from. And they should know that those places are FDA approved and inspected. And the second thing is they should require adverse event reporting. Those are required of 503Bs. They should be required of 503As as well. 503As are making a tremendous amount of money. They're making thousands and thousands of these scripts. So when there are adverse events, they should be required to report those to the FDA. Simple. None of that is in this bill. None of it. None of it. Instead, it seeks to put caps on the amount of compounds that can be made by a compound pharmacy without them having to report to the FDA. And then it seeks to codify the definition of essential copy. Again, all of these things that will become law and then argued in court and then a battlefield for Lilly to potentially win a legal battle and thwart compounding. It's creating a new battlefield for them. They're losing in the courts. They're losing with the current language that exists in the Food, Drug, and Cosmetic Act. So we create new language. We create new law. Just vague enough to pull some threads and hopefully win something in court. That's how I see it. You may see it differently. If you do, curious to hear from you. But if you want to fight back against this legislation, you can go to otplinks.com and fight back against that. piece of legislation, because I think that we need as a community to have our voices heard on this, especially those who have gotten healthier by way of compounded medications. So the rumor on the gray market, to get back and close the thought loop here, There's been no specific FDA cutoff announced, but what the rumors going around are that that the compounded versions of GLP ones, especially obesity medicine in the gray market, are all going to turn off like a sieve on January first. Now, I seem to feel like this is probably more of a marketing tactic by these companies to sell a whole bunch of peptides at the end of the year. I think that's probably creating some panic and probably panic buying on people's parts. And so these companies are benefiting greatly. Again, that's why there should be guardrails around this. There's no guardrails around this at all. I mean, at the end of the day, they can say whatever they want to say, so long as they cloak everything in research grade. And these rumors proliferate around and people spend thousands, tens of thousands of dollars. I've heard of people having twenty years worth of Retatrutide in their freezer. Why? For what purpose do you need that? So just a massive amount of money made in this gray market. And that's not to knock people who use it. I say this all the time, but I think it's worth qualifying the statement. It's not knocking people who use it. I get it. But at the same time, we're talking about an industry that is, there's no altruism here. They're in it for money just as much as Eli Lilly is, except they have actually done nothing in the way of advancing medicine. They've just taken intellectual property, copied it, and sold it to you with a label that says, don't put this in your body. So you know where I stand on the gray market. I've heard from many people who've been injured by gray market stuff. It's just what it is. It's a gray market. You're taking your health into your own hands. Please, whatever you're doing out there, as risky as it may be, please involve your doctor and let your doctor know what you're doing so you can be monitored for the things your doctor believes you should be monitored for if you're using this. But this all underscores, again, the need for accessibility to these medications, the need for us to be aware of the fact that a moat is already being built around the most advanced metabolic drug in the pipeline. And we just need to be aware so that when it comes time to fight, we're all ready and informed. And that's what this podcast is serving to do. Before we jump into the next topic, I do want to thank our sponsor, our headline sponsor of this podcast. is a company called Shed. Now, if you are looking for access to care for obesity, then look no further than our partners at Shed who believed in this podcast enough to help us do it full time. You can go to Trished.com and use code OTP25 to save twenty five percent at Trished.com, where you're going to get connected to a doctor who will when medically necessary prescribe medication to treat your obesity. You also get access to coaching. You'll get access to all sorts of medication, whether it's the branded or the compounded versions, depending on your specific situation. All of it is available at Trished.com. They use one of my favorite compound pharmacies in the game, Strive Pharmacy, which I've gotten the chance to dig into on my own. I really love what they do there. They're a It functionally operates a lot more like a 503B. Uh, and I think that they're doing great work over at a strive pharmacy. They partner with shed. So I just love this, this, and when we were looking for somebody to offer a compounded versions, I wanted to make sure that I trusted the pharmacy. People always ask me, Dave, who, who should I go to? I'm like the pharmacy matters more than anything because you want to trust the source of your medication. So try shed.com use code OTP25. Listen, you're going to want to learn about taking any new medication before you take it. Learn about the potential side effects. Learn about the trade offs. There's no free lunch, but all of the information that you're going to need, you can find it. Try shed.com and be familiarizing yourself with all of your options there. So thank you to Shed for being a wonderful partner here at On The Pen. Now let's talk about some data that dropped. We're talking about accessibility and all of the sort of advancements in the world mean very little if people can't access it. That's why I think this data that dropped this past week from our friends over at Rowe is incredible. Absolutely game changing data. So check out this data. Real world telehealth data looking at sixty eight weeks. This is looking at patients who were enrolled in their row body program and on a GLP one specifically some maglutide mean weight loss in this study looked at again patients in over sixty eight weeks. The mean weight loss was sixteen point six percent on average. Thirty three percent of patients lost more than twenty percent and the safety in this study and looking at this data match the clinical trials. So what we're seeing here is that care for obesity can be delivered through a telehealth platform at scale and match clinical trial results. So that scalability decides how many people get access. There are not enough doctors out there to serve the over hundred million people in the United States living with overweight or obesity. so when you hear these blowhard doctors online calling all telehealth platforms except their own a pill mill or as i like to say pin mill the data is actually showing something quite different in that this type of obesity care can be delivered at scale through telehealth platforms it can meet people where they're at and allow people to get care without the shame, without the stigma, without their doctor just pointing to the door and saying, if you want a GLP-I, get out of my office. I ain't going to get it here. How ridiculous. But these people can go to platforms like Rho or Shed or any number of telehealth platforms that are out there and not only get access to medicine, but get access to care. So of course, not all telehealth companies are created equal. Of course, not all compound pharmacies are created equal. You want to do your homework and all of that. But this is data that shows that This kind of care can be delivered at scale via a virtual platform and show similar results to a clinical trial. I think, and this is peer reviewed data, and I think that this is just absolutely great news because when we talk about the problem, we need scalable solutions. The old brick and mortar ain't going to work when you don't have enough doctors to serve enough patients. If we want to get life-changing treatments like ritatratide or terzapatide, semaglutide, whatever, into the hands of the people who need it the most, we need companies to innovate scalable tech platforms that can meet patients where they are, that can leverage current technologies to find people the care that they need. And in this case, it's access to a doctor. It's access to a platform. It's access to prescription medication when appropriately prescribed. And it can be done, and it is being done. So I think this is great news, and will play a huge part in the future. As we talk about Retatrutide, even though it's a year and a half away, maybe a little bit longer, it's already exposing – the issues around accessibility and pricing. Hopefully there will be compounded versions available if they're medically necessitated, if there are shortages. We hope that the battleground for that is not already set and won by Lilly before this drug even comes to market. But there are strategies being done to keep people boxed out But I can tell you that whatever happens with Retatrutide, the future of obesity medicine is in virtual care. And platforms are rising to the occasion. Retatrutide hasn't reached patients yet, but it's already forcing the system to show us, you know, are you ready? Are you ready to deliver bariatric surgery level results at scale to the people who need them? So I am so thankful that you joined me here on this podcast today. Again, we love to talk about we're at a Retatrutide. If you're interested, we've been going live every Monday, Wednesday and Friday at eleven a.m. Central Time here on our YouTube channel, on our tick tock, on our X platform. We're doing that because there's enough news to bring you just about every single day. And we've been doing it for the last couple of weeks. If you've enjoyed it, let me know in the comments of the video on YouTube. Send me an email at David on the pen dot com. Uh, so every single Monday, Wednesday, Friday, and then we do a weekly rundown of the obesity medicine news every Tuesday. That's what this is. The weekly dose podcast. You can catch this on all of the platforms that you listen to your podcasts on, and please make sure to leave us a five star rating and review before you log out of your podcast app. That helps so much. I don't think you guys understand how much that helps, uh, the work that we do here to just train the podcast algorithms that this one is worth listening to. I hope you enjoyed today's podcast. If you did, drop it a thumbs up, five-star review, subscribe on YouTube, do all the things. Thank you for being here, and thank you for being the best part of what we do. We will catch you on the next one. Thank you, my friends. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Recorded at the 2025 Emerging Drug Trends Conference in Dallas, the Tall Cop sits down with Michael Blute, Georgia's State Drug Recognition Expert (DRE) Coordinator, to discuss what he's seeing on the roads and in communities. They break down current drug trends, the rise of poly-drug use, how officers are trained as DREs, and the evolving challenges of identifying drug-impaired driving. A must-listen for law enforcement, prevention professionals, and anyone working to keep communities safe. Save the Date for the 5th Annual Tall Cop Emerging Drug Trends Conference on 11/12-13/2026!Follow us on ⁠Facebook⁠, ⁠Instagram⁠, ⁠YouTube⁠, and ⁠LinkedIn.⁠Subscribe to our ⁠monthly newsletter here⁠!Learn more about the ⁠Tall Cop Speaker's Network!⁠

Dr. Dubrow names the GLP-1 that will take over 2026. Meanwhile, Heather takes a ‘jab’ at post-Ozempic beauty standards, and who is Terry telling to STFU?See omnystudio.com/listener for privacy information.

Which is the safest and most effective statin?

Shannon Davis, a Registered Dietitian Nutritionist with more than 19 years of experience specializing in metabolic health and insulin resistance. She's a founding board member of the American Diabetes Society, an Insulin IQ Coach, and the founder of a successful virtual metabolic health practice where she's helped nearly a thousand people reverse insulin resistance, lose weight, and even put type 2 diabetes into remission. Shannon's background spans dialysis, organ transplant, bariatrics, and pharmaceutical sales — giving her a unique perspective on why food, not medication, is the real solution to most dietary conditions. She's been featured on over 50 podcasts as an expert in metabolic health, and when she's not helping people transform their lives, you'll find her in the gym doing CrossFit or spending time riding horses — her lifelong passion. Instagram: https://www.instagram.com/sldavis6580 X: https://x.com/fittoeat6580 YouTube: https://youtube.com/@shannondavis1619 Facebook: https://www.facebook.com/shannon.davis.9279 Website: https://shannonfeelgreat.com/ Timestamps: 00:00 Trailer 00:53 Introduction 05:31 Renal care challenges and ethics 09:11 Kidney health and low-carb diets 10:41 Keto and kidney care 13:44 Dialysis conflict of interest 18:39 Diabetes advocacy and carnivore 21:16 Ketogenic diets and diabetes 24:02 Preventing heart disease 28:16 Diet wars and social media 31:26 Better living through medication 34:04 Platform censorship frustrations  37:14 Grassroots health movement challenges 42:51 AI transforming pharmaceutical marketing 43:30 Drug industry priorities  49:16 Low carb diet and cholesterol 50:29 Where to find Shannon 53:43 United in the fight Join Revero now to regain your health: https://revero.com/YT Revero.com is an online medical clinic for treating chronic diseases with this root-cause approach of nutrition therapy. You can get access to medical providers, personalized nutrition therapy, biomarker tracking, lab testing, ongoing clinical care, and daily coaching. You will also learn everything you need with educational videos, hundreds of recipes, and articles to make this easy for you. Join the Revero team (medical providers, etc): https://revero.com/jobs ‪#Revero #ReveroHealth #shawnbaker  #Carnivorediet #MeatHeals #AnimalBased #ZeroCarb #DietCoach  #FatAdapted #Carnivore #sugarfree Disclaimer: The content on this channel is not medical advice. Please consult your healthcare provider.